AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| PAI | Ann: Weekly Net Tangible Asset Backing | 24/04/18 | 0 | 18 | |||
|
|||||||
| PAI | Ann: Weekly Net Tangible Asset Backing | 17/04/18 | 0 | 63 | |||
|
|||||||
| PAI | Ann: March 2018 Quarterly Investment Manager's Report | 16/04/18 | 0 | 70 | |||
|
|||||||
| PAI | Ann: Weekly Net Tangible Asset Backing | 10/04/18 | 0 | 69 | |||
|
|||||||
| PAI | Ann: Net Tangible Asset Backing - March 2018 | 09/04/18 | 0 | 63 | |||
|
|||||||
| PAI | Ann: Initial Director's Interest Notice | 03/04/18 | 0 | 43 | |||
|
|||||||
| PAI | Ann: Final Director's Interest Notice | 03/04/18 | 0 | 39 | |||
|
|||||||
| PAI | Ann: Weekly Net Tangible Asset Backing | 27/03/18 | 0 | 89 | |||
|
|||||||
See All Discussions
ASX News